These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3150831)

  • 1. [Therapy of hepatic encephalopathy].
    Grüngreiff K
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(5):250-60. PubMed ID: 3150831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
    Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
    Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of the effect of a protein-free diet and branched-chain amino acids (preparation Aminosteril-Hepa) on selected biochemical indicators in chronic experimental hepatic encephalopathy].
    Boroń P; Szpakowicz T; Farbiszewski R; Flisiak R; Nowak H; Pytel B; Zimnoch L
    Neuropatol Pol; 1989; 27(3):437-47. PubMed ID: 2517893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
    Zavaglia C; Brivio M; Losacco E; Onida L
    Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of hepatic encephalopathy].
    Egberts EH
    Leber Magen Darm; 1987 Aug; 17(4):244, 247-62, 265-73. PubMed ID: 3312884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of nutrition in hepatic encephalopathy.
    Schulz GJ; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):275-80. PubMed ID: 18403924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parenteral nutrition in liver insufficiency].
    Kleinberger G
    Schweiz Med Wochenschr; 1986 Apr; 116(17):545-9. PubMed ID: 3086972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic coma. Principles of pathogenesis and treatment. 2: Treatment, prognosis].
    Müting D; Reikowski J
    Fortschr Med; 1983 Oct; 101(39):1766-73. PubMed ID: 6642382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protein and amino acid metabolism in liver failure--therapeutic infusion and dietary sequelae].
    Holm E; Leweling H; Staedt U; Striebel JP; Tschepe A; Uhl W
    Verh Dtsch Ges Inn Med; 1986; 92():685-737. PubMed ID: 3101309
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is guaranteed in the therapy of hepatic encephalopathy?].
    Plauth M; Egberts EH
    Internist (Berl); 1993 Jan; 34(1):35-42. PubMed ID: 8440573
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional support of patients with severe hepatic failure.
    Barber JR; Teasley KM
    Clin Pharm; 1984; 3(3):245-53. PubMed ID: 6428797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of chronic hepatic encephalopathy.
    Morgan MY
    Hepatogastroenterology; 1991 Oct; 38(5):377-87. PubMed ID: 1662661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
    Ferenci P; Wewalka F
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis and therapy of hepatic coma].
    Zeichen R
    Wien Med Wochenschr; 1986 Mar; 136(5-6):130-3. PubMed ID: 3727604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids--a case report.
    Fukuda K; Yao H; Murai K; Ibayashi S; Fujishima M
    Fukuoka Igaku Zasshi; 1999 Dec; 90(12):464-9. PubMed ID: 10655667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valine and branched-chain amino acids in the treatment of hepatic encephalopathy].
    Grüngreiff K; Kleine FD; Musil HE; Diete U; Franke D; Klauck S; Päge I; Kleine S; Lössner B; Pfeiffer KP
    Z Gastroenterol; 1993 Apr; 31(4):235-41. PubMed ID: 8493803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of cirrhotic hepatic encephalopathy. Treatment implications].
    García-Compean D; Michel H
    Rev Gastroenterol Mex; 1995; 60(3):159-68. PubMed ID: 7481451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.